We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Large PACS/RIS Replacement Project Announced in Turkey

By MedImaging International staff writers
Posted on 08 Apr 2015
Print article
Image: The FujiFilm Synapse PACS (Photo courtesy of FujiFilm).
Image: The FujiFilm Synapse PACS (Photo courtesy of FujiFilm).
The Medical Park Group (Istanbul, Turkey) has concluded a five-year PACS/RIS replacement project for all 30 hospitals in the group.

The PACS system selected is the FujiFilm Europe (Duesseldorf, Germany) Synapse PACS and positions FujiFilm as the most widely used medical informatics vendor and global leader among PACS vendors.

The Synapse PACS provides radiologists with advanced visualization tools to assist radiologists, surgeons, and clinicians with diagnosis, pre-operative planning, and clinical decision support. The Synapse PACS Clinical Workflow Manager (CWM) is intended to enhance access to patient data, and improves the efficiency of the clinical reporting workflow. The Synapse PACS enables the archiving and distribution of image information from all modalities, uses next-generation Web technology, and Wavelet on-demand compression.

Yuksel Yazici, deputy director of the Biomedical Department at the Medical Park Group, said, “This supports us in our mission to provide qualified healthcare services to our international patients.”

Related Links:

FujiFilm Europe
Medical Park Group



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
PACS Workstation
CHILI Web Viewer
Portable Radiology System
DRAGON ELITE & CLASSIC
New
Ultrasound System
P20 Elite

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.